Tatsuo Kimura, S. Fukumoto, Akemi Nakano, H. Fujii, Yuji Nadatani, Yukie Tauchi, Shingo Takashima, Yuko Nishii, K. Otani, Naomi Ageshio, T. Suzumura, N. Kawada
{"title":"与第一次筛查相比,重复肺癌筛查显示较少的不同变异的CXR异常","authors":"Tatsuo Kimura, S. Fukumoto, Akemi Nakano, H. Fujii, Yuji Nadatani, Yukie Tauchi, Shingo Takashima, Yuko Nishii, K. Otani, Naomi Ageshio, T. Suzumura, N. Kawada","doi":"10.15761/hpc.1000210","DOIUrl":null,"url":null,"abstract":"Objectives: Chest radiography (CXR) is the most common screening procedure for the detection of lung cancer. A comparative CXR review can help to detect new shadows. Participants (pts) who undergo repeated screening at the same facility as the health check-up can receive a comparative review of the CXR. It has been hypothesized that the diagnosis of CXR abnormalities in screening would be different when compared to previous CXR and when not. Methods: We retrospectively analyzed one-year cohort derived from the ongoing MedCity21 health check-up registry. The pts with abnormalities requiring medication in CXR were invited to our clinic for chest computed tomography (CT). We compared the varieties of abnormalities on CXR between repeated and first-visit pts using chi-square tests. Results: A total of 13,690 repeated / first visits of 7872 / 5818 (57.5 / 42.5%) pts were enrolled. The CXR abnormalities included 324 of 143 / 191 pts and 234 of 108 / 126 pts who underwent chest CT, respectively. Repeated pts had a significantly lower proportion of abnormalities in CXR that required medication than the first-visit pts (p < 0.01). CT confirmation revealed that CXR abnormalities in repeated pts were diagnosed with different variations compared to those of first-visit pts. Repeated pts had a significantly lower proportion of old inflammatory changes (p=0.02) and a higher proportion of acute inflammatory shadow (p=0.02) than first-visit pts. Conclusions: Immediate confirmation by CT revealed that CXR abnormalities in repeated pts were diagnosed with different variations compared to those of firsttime pts. A comparative review of previous CXR may be highly effective in ruling out lung cancer. *Correspondence to: Tatsuo Kimura, M.D. Ph.D., Department of Premier Preventive Medicine, Graduate School of Medicine, Osaka City University, 1-143 AbenoHARUKAS 21F, Abenosuji, Abeno-ku Osaka 545-6090, Japan, Tel: 81-6-6624-4041; Fax: 81-6-6624-8212; E-mail: kimutats@med.osaka-cu.ac.jp","PeriodicalId":48703,"journal":{"name":"Primary Health Care Research and Development","volume":"11 1","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Repeat lung cancer screenings reveal less CXR abnormalities with different variations than first-time screening\",\"authors\":\"Tatsuo Kimura, S. Fukumoto, Akemi Nakano, H. Fujii, Yuji Nadatani, Yukie Tauchi, Shingo Takashima, Yuko Nishii, K. Otani, Naomi Ageshio, T. Suzumura, N. Kawada\",\"doi\":\"10.15761/hpc.1000210\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: Chest radiography (CXR) is the most common screening procedure for the detection of lung cancer. A comparative CXR review can help to detect new shadows. Participants (pts) who undergo repeated screening at the same facility as the health check-up can receive a comparative review of the CXR. It has been hypothesized that the diagnosis of CXR abnormalities in screening would be different when compared to previous CXR and when not. Methods: We retrospectively analyzed one-year cohort derived from the ongoing MedCity21 health check-up registry. The pts with abnormalities requiring medication in CXR were invited to our clinic for chest computed tomography (CT). We compared the varieties of abnormalities on CXR between repeated and first-visit pts using chi-square tests. Results: A total of 13,690 repeated / first visits of 7872 / 5818 (57.5 / 42.5%) pts were enrolled. The CXR abnormalities included 324 of 143 / 191 pts and 234 of 108 / 126 pts who underwent chest CT, respectively. Repeated pts had a significantly lower proportion of abnormalities in CXR that required medication than the first-visit pts (p < 0.01). CT confirmation revealed that CXR abnormalities in repeated pts were diagnosed with different variations compared to those of first-visit pts. Repeated pts had a significantly lower proportion of old inflammatory changes (p=0.02) and a higher proportion of acute inflammatory shadow (p=0.02) than first-visit pts. Conclusions: Immediate confirmation by CT revealed that CXR abnormalities in repeated pts were diagnosed with different variations compared to those of firsttime pts. A comparative review of previous CXR may be highly effective in ruling out lung cancer. *Correspondence to: Tatsuo Kimura, M.D. Ph.D., Department of Premier Preventive Medicine, Graduate School of Medicine, Osaka City University, 1-143 AbenoHARUKAS 21F, Abenosuji, Abeno-ku Osaka 545-6090, Japan, Tel: 81-6-6624-4041; Fax: 81-6-6624-8212; E-mail: kimutats@med.osaka-cu.ac.jp\",\"PeriodicalId\":48703,\"journal\":{\"name\":\"Primary Health Care Research and Development\",\"volume\":\"11 1\",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Primary Health Care Research and Development\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.15761/hpc.1000210\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PRIMARY HEALTH CARE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary Health Care Research and Development","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15761/hpc.1000210","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
Repeat lung cancer screenings reveal less CXR abnormalities with different variations than first-time screening
Objectives: Chest radiography (CXR) is the most common screening procedure for the detection of lung cancer. A comparative CXR review can help to detect new shadows. Participants (pts) who undergo repeated screening at the same facility as the health check-up can receive a comparative review of the CXR. It has been hypothesized that the diagnosis of CXR abnormalities in screening would be different when compared to previous CXR and when not. Methods: We retrospectively analyzed one-year cohort derived from the ongoing MedCity21 health check-up registry. The pts with abnormalities requiring medication in CXR were invited to our clinic for chest computed tomography (CT). We compared the varieties of abnormalities on CXR between repeated and first-visit pts using chi-square tests. Results: A total of 13,690 repeated / first visits of 7872 / 5818 (57.5 / 42.5%) pts were enrolled. The CXR abnormalities included 324 of 143 / 191 pts and 234 of 108 / 126 pts who underwent chest CT, respectively. Repeated pts had a significantly lower proportion of abnormalities in CXR that required medication than the first-visit pts (p < 0.01). CT confirmation revealed that CXR abnormalities in repeated pts were diagnosed with different variations compared to those of first-visit pts. Repeated pts had a significantly lower proportion of old inflammatory changes (p=0.02) and a higher proportion of acute inflammatory shadow (p=0.02) than first-visit pts. Conclusions: Immediate confirmation by CT revealed that CXR abnormalities in repeated pts were diagnosed with different variations compared to those of firsttime pts. A comparative review of previous CXR may be highly effective in ruling out lung cancer. *Correspondence to: Tatsuo Kimura, M.D. Ph.D., Department of Premier Preventive Medicine, Graduate School of Medicine, Osaka City University, 1-143 AbenoHARUKAS 21F, Abenosuji, Abeno-ku Osaka 545-6090, Japan, Tel: 81-6-6624-4041; Fax: 81-6-6624-8212; E-mail: kimutats@med.osaka-cu.ac.jp
期刊介绍:
Primary Health Care Research & Development is aimed specifically at both researchers and practitioners in primary health care, bridging the gap between the two areas. It provides a forum for the publication of international, interdisciplinary research and development in primary health care. It is essential reading for all involved in primary care: nurse practitioners, GPs and health service managers; professional and local groups in community health; researchers and academics; purchasers of primary health care services; allied health practitioners in secondary services and health-related consumer groups.